Cargando…

Ciclosporin/rituximab: Lack of efficacy and COVID-19: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726285/ http://dx.doi.org/10.1007/s40278-020-86939-8

Ejemplares similares

Ciclosporin/corticotropin/rituximab: Acute kidney injury, transient liver damage and lack of efficacy: case report
Publicado: (2021)

Antithymocyte-globulin/ciclosporin/eltrombopag: Lack of efficacy: case report
Publicado: (2022)

Ciclosporin/mycophenolate mofetil: Lack of efficacy and off-label use: case report
Publicado: (2022)

Acitretin/ciclosporin: Lack of efficacy during treatment of palmar psoriasis: case report
Publicado: (2022)

Ciclosporin/everolimus/rituximab: COVID-19, Epstein-Barr virus infection and COVID-19 reinfection: case report
Publicado: (2021)

BCG-vaccine/ciclosporin/methotrexate/methylprednisolone: Lack of efficacy and disseminated BCGosis: 2 case reports
Publicado: (2021)

Ciclosporin/methylprednisolone: COVID-19 infection: case report
Publicado: (2022)

Ciclosporin/methylprednisolone: COVID-19 infection: case report
Publicado: (2022)

COVID-19 vaccines/rituximab: Lack of efficacy: 6 case reports
Publicado: (2021)

Rituximab/methotrexate: Lack of efficacy: case report
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech/ciclosporin/mycophenolate sodium: Vogt-Koyanagi-Harada disease reactivation and lack of efficacy: case report
Publicado: (2021)

Ciclosporin/everolimus/prednisone: COVID-19 pneumonia: case report
Publicado: (2021)

Ciclosporin: Various toxicities: case report
Publicado: (2022)

Ciclosporin/mycophenolate-mofetil/steroids: COVID-19 pneumonia: case report
Publicado: (2021)

Immune-globulin/rituximab: Lack of efficacy: case report
Publicado: (2021)

Ciclosporin/methylprednisolone/tocilizumab: COVID-19 pneumonia, leukopenia and neutropenia: case report
Publicado: (2020)

Mycophenolate mofetil/ciclosporin/prednisolone: COVID-19 infection: 2 case reports
Publicado: (2021)

Ciclosporin/prednisolone: COVID-19 infection and Klebsiella pneumoniae septicaemia: case report
Publicado: (2022)

Acitretin/ciclosporin: Treatment failure : case report
Publicado: (2021)

Ciclosporin/prednisone: Visceral leishmaniasis: case report
Publicado: (2022)

Dapsone/rituximab: Serum sickness and lack of efficacy: case report
Publicado: (2022)

Covid-19-vaccine/rituximab: COVID-19 infection and lack of efficacy caused by drug interactions: case report
Publicado: (2021)

Chloroquine/favipiravir/rituximab: COVID-19-pneumonia, off-label use and lack of efficacy: case report
Publicado: (2022)

Ciclosporin/tozinameran: Behcet's disease and hepatic damage: 2 case reports
Publicado: (2022)

AZD-1222/ciclosporin: Reactivation of recurrent herpes zoster: 3 case reports
Publicado: (2021)

Ciclosporin/tozinameran: Vaccination failure and poor serological response: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir/rituximab: Hypotension, dyspnoea and lack of efficacy following off-label use: case report
Publicado: (2021)

Ciclosporin/steroids: Pandemic (H1N1)-associated ARDS: case report
Publicado: (2013)

Ciclosporin/cyclophosphamide/mycophenolate mofetil: Bacterial, viral and fungal infections: 71 case reports
Publicado: (2019)

Rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19: case report
Publicado: (2022)

Rituximab: COVID-19: case report
Publicado: (2022)

Ciclosporin 10 years on: indications and efficacy
por: Forsythe, Peter, et al.
Publicado: (2014)

Mycophenolate mofetil/prednisolone/rituximab: SARS-CoV-2 infection and lack of efficacy: 2 case reports
Publicado: (2022)

AZD-1222/immune-globulin/rituximab: Coronary antibody-mediated rejection, thrombosis and lack of efficacy: case report
Publicado: (2022)

Ciclosporin/interferon-beta-1a: Various toxicities and off-label use: case report
Publicado: (2022)

Immune-globulin: Lack of efficacy in COVID-19: case report
Publicado: (2021)

Immunosuppressants and antiviral: COVID-19 and lack of efficacy: case report
Publicado: (2022)

Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathy
por: Caihong, Qu, et al.
Publicado: (2013)

Cefepime/convalescent-anti-sars-cov-2-plasma/rituximab: Relapsed COVID-19 and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qdq0ju688qpunau5gtpbqo5vpg